Barjaktarovic Mirjana, Korevaar Tim I M, Jaddoe Vincent W V, de Rijke Yolanda B, Visser Theo J, Peeters Robin P, Steegers Eric A P
The Generation R Study Group, Departments of Internal Medicine, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands.
Departments of Internal Medicine, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands.
Eur J Epidemiol. 2017 Feb;32(2):135-144. doi: 10.1007/s10654-016-0201-3. Epub 2016 Oct 5.
Human chorionic gonadotropin (hCG) is a pregnancy-specific hormone that regulates placental development. hCG concentrations vary widely throughout gestation and differ based on fetal sex. Abnormal hCG concentrations are associated with adverse pregnancy outcomes including fetal growth restriction. We studied the association of hCG concentrations with fetal growth and birth weight. In addition, we investigated effect modification by gestational age of hCG measurement and fetal sex. Total serum hCG (median 14.4 weeks, 95 % range 10.1-26.2), estimated fetal weight (measured by ultrasound during 18-25th weeks and >25th weeks) and birth weight were measured in 7987 mother-child pairs from the Generation R cohort and used to establish fetal growth. Small for gestational age (SGA) was defined as a standardized birth weight lower than the 10th percentile of the study population. There was a non-linear association of hCG with birth weight (P = 0.009). However, only low hCG concentrations measured during the late first trimester (11th and 12th week) were associated with birth weight and SGA. Low hCG concentrations measured in the late first trimester were also associated with decreased fetal growth (P = 0.0002). This was the case for both male and female fetuses. In contrast, high hCG concentrations during the late first trimester were associated with increased fetal growth amongst female, but not male fetuses. Low hCG in the late first trimester is associated with lower birth weight due to a decrease in fetal growth. Fetal sex differences exist in the association of hCG concentrations with fetal growth.
人绒毛膜促性腺激素(hCG)是一种调节胎盘发育的妊娠特异性激素。hCG浓度在整个孕期变化很大,并且因胎儿性别而异。异常的hCG浓度与包括胎儿生长受限在内的不良妊娠结局相关。我们研究了hCG浓度与胎儿生长及出生体重之间的关联。此外,我们还调查了hCG测量时的孕周和胎儿性别对效应的修正作用。在来自Generation R队列的7987对母婴中测量了总血清hCG(中位数14.4周,95%范围10.1 - 26.2)、估计胎儿体重(在第18至25周及大于25周时通过超声测量)和出生体重,并用于确定胎儿生长情况。小于胎龄儿(SGA)定义为标准化出生体重低于研究人群的第10百分位数。hCG与出生体重呈非线性关联(P = 0.009)。然而,只有在孕早期晚期(第11和12周)测量的低hCG浓度与出生体重和SGA相关。孕早期晚期测量的低hCG浓度也与胎儿生长减少相关(P = 0.0002)。男性和女性胎儿均如此。相比之下,孕早期晚期的高hCG浓度与女性胎儿而非男性胎儿的生长增加相关。孕早期晚期的低hCG由于胎儿生长减少而与较低的出生体重相关。hCG浓度与胎儿生长的关联存在胎儿性别差异。